Predicting the spatio-temporal response of recurrent glioblastoma treated with rhenium-186 labelled nanoliposomes
Brain Multiphysics(2023)
摘要
Rhenium-186 (186Re) labeled nanoliposome (RNL) therapy for recurrent glioblastoma patients has shown promise to improve outcomes by locally delivering radiation to affected areas. To optimize the delivery of RNL, we have developed a framework to predict patient-specific response to RNL using image-guided mathematical models.
更多查看译文
关键词
recurrent glioblastoma,spatio-temporal
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要